Literature DB >> 30655318

Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages.

Mithila Vaidya1,2, Julian A Jentsch1,2, Susann Peters1,2, Petra Keul1,2, Sarah Weske1,2, Markus H Gräler3,4,5, Emil Mladenov6, George Iliakis6, Gerd Heusch1,2, Bodo Levkau7,2.   

Abstract

Sphingolipid and cholesterol metabolism are closely associated at the structural, biochemical, and functional levels. Although HDL-associated sphingosine-1-phosphate (S1P) contributes to several HDL functions, and S1P signaling regulates glucose and lipid metabolism, no study has addressed the involvement of S1P in cholesterol efflux. Here, we show that sphingosine kinase (Sphk) activity was induced by the LXR agonist 22(R)-hydroxycholesterol and required for the stimulation of ABCA1-mediated cholesterol efflux to apolipoprotein A-I. In support, pharmacological Sphk inhibition and Sphk2 but not Sphk1 deficiency abrogated efflux. The involved mechanism included stimulation of both transcriptional and functional ABCA1 regulatory pathways and depended for the latter on the S1P receptor 3 (S1P3). Accordingly, S1P3-deficient macrophages were resistant to 22(R)-hydroxycholesterol-stimulated cholesterol efflux. The inability of excess exogenous S1P to further increase efflux was consistent with tonic S1P3 signaling by a pool of constitutively generated Sphk-derived S1P dynamically regulating cholesterol efflux. In summary, we have established S1P as a previously unrecognized intermediate in LXR-stimulated ABCA1-mediated cholesterol efflux and identified S1P/S1P3 signaling as a positive-feedback regulator of cholesterol efflux. This constitutes a novel regulatory mechanism of cholesterol efflux by sphingolipids.
Copyright © 2019 Vaidya et al.

Entities:  

Keywords:  ATP binding cassette transporter A1; S1P receptor 3; apolipoprotein A-I; atherosclerosis; high density lipoprotein; reverse cholesterol transport; sphingosine kinases; sphingosine-1-phosphate

Mesh:

Substances:

Year:  2019        PMID: 30655318      PMCID: PMC6399502          DOI: 10.1194/jlr.M088443

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  42 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

Review 2.  Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.

Authors:  Clara Cavelier; Iris Lorenzi; Lucia Rohrer; Arnold von Eckardstein
Journal:  Biochim Biophys Acta       Date:  2006-05-04

Review 3.  Transcriptional regulatory networks in lipid metabolism control ABCA1 expression.

Authors:  Gerd Schmitz; Thomas Langmann
Journal:  Biochim Biophys Acta       Date:  2005-06-15

4.  ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages.

Authors:  J F Oram; R M Lawn; M R Garvin; D P Wade
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

5.  A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.

Authors:  A Chawla; W A Boisvert; C H Lee; B A Laffitte; Y Barak; S B Joseph; D Liao; L Nagy; P A Edwards; L K Curtiss; R M Evans; P Tontonoz
Journal:  Mol Cell       Date:  2001-01       Impact factor: 17.970

6.  Ceramide enhances cholesterol efflux to apolipoprotein A-I by increasing the cell surface presence of ATP-binding cassette transporter A1.

Authors:  Scott R Witting; J Nicholas Maiorano; W Sean Davidson
Journal:  J Biol Chem       Date:  2003-07-30       Impact factor: 5.157

7.  Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly.

Authors:  Yoshio Yamauchi; Michi Hayashi; Sumiko Abe-Dohmae; Shinji Yokoyama
Journal:  J Biol Chem       Date:  2003-09-02       Impact factor: 5.157

8.  Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes.

Authors:  Koichi Sato; Enkhzol Malchinkhuu; Yuta Horiuchi; Chihiro Mogi; Hideaki Tomura; Masahiko Tosaka; Yuhei Yoshimoto; Atsushi Kuwabara; Fumikazu Okajima
Journal:  J Neurochem       Date:  2007-12       Impact factor: 5.372

9.  Discovery and evaluation of inhibitors of human sphingosine kinase.

Authors:  Kevin J French; Randy S Schrecengost; Brian D Lee; Yan Zhuang; Staci N Smith; Justin L Eberly; Jong K Yun; Charles D Smith
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

Review 10.  Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Bevra H Hahn; Jennifer Grossman; Benjamin J Ansell; Brian J Skaggs; Maureen McMahon
Journal:  Arthritis Res Ther       Date:  2008-08-29       Impact factor: 5.156

View more
  14 in total

Review 1.  Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Authors:  Ioanna Andreadou; Rainer Schulz; Lina Badimon; Adriana Adameová; Petra Kleinbongard; Sandrine Lecour; Panagiota-Efstathia Nikolaou; Ines Falcão-Pires; Gemma Vilahur; Nicholas Woudberg; Gerd Heusch; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

2.  Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.

Authors:  Jens Pahnke; Pablo Bascuñana; Mirjam Brackhan; Katja Stefan; Vigneshwaran Namasivayam; Radosveta Koldamova; Jingyun Wu; Luisa Möhle; Sven Marcel Stefan
Journal:  Free Neuropathol       Date:  2021-12-13

3.  Metabolic-related gene pairs signature analysis identifies ABCA1 expression levels on tumor-associated macrophages as a prognostic biomarker in primary IDHWT glioblastoma.

Authors:  Shiqun Wang; Lu Li; Shuguang Zuo; Lingkai Kong; Jiwu Wei; Jie Dong
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

4.  Mechanistic convergence and shared therapeutic targets in Niemann-Pick disease.

Authors:  Alexandria Colaco; Ecem Kaya; Elias Adriaenssens; Lianne C Davis; Stefania Zampieri; María E Fernández-Suárez; Chong Y Tan; Patrick B Deegan; Forbes D Porter; Antony Galione; Bruno Bembi; Andrea Dardis; Frances M Platt
Journal:  J Inherit Metab Dis       Date:  2019-12-05       Impact factor: 4.750

Review 5.  Arterial Lymphatics in Atherosclerosis: Old Questions, New Insights, and Remaining Challenges.

Authors:  Gábor Csányi; Bhupesh Singla
Journal:  J Clin Med       Date:  2019-04-11       Impact factor: 4.241

Review 6.  Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases.

Authors:  Elena M G Diarte-Añazco; Karen Alejandra Méndez-Lara; Antonio Pérez; Núria Alonso; Francisco Blanco-Vaca; Josep Julve
Journal:  Int J Mol Sci       Date:  2019-12-12       Impact factor: 5.923

Review 7.  Sphingolipids in metabolic disease: The good, the bad, and the unknown.

Authors:  Christopher D Green; Michael Maceyka; L Ashley Cowart; Sarah Spiegel
Journal:  Cell Metab       Date:  2021-07-06       Impact factor: 31.373

Review 8.  Sphingosine-1-Phosphate and Macrophage Biology-How the Sphinx Tames the Big Eater.

Authors:  Andreas Weigert; Catherine Olesch; Bernhard Brüne
Journal:  Front Immunol       Date:  2019-07-19       Impact factor: 7.561

9.  Sphingosine kinase-2 prevents macrophage cholesterol accumulation and atherosclerosis by stimulating autophagic lipid degradation.

Authors:  Kazuhiro Ishimaru; Kazuaki Yoshioka; Kuniyuki Kano; Makoto Kurano; Daisuke Saigusa; Junken Aoki; Yutaka Yatomi; Noriko Takuwa; Yasuo Okamoto; Richard L Proia; Yoh Takuwa
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379

Review 10.  The role of sphingosine 1-phosphate and its receptors in cardiovascular diseases.

Authors:  Jie Ouyang; Zhihao Shu; Shuhua Chen; Hong Xiang; Hongwei Lu
Journal:  J Cell Mol Med       Date:  2020-08-17       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.